JubilantLife slips 4% as USFDA recommends action against plant

JubilantLife slips 4% as USFDA recommends action against plant

Monday, December 10, 2018

Shares of Jubilant Life Sciences slipped 4 percent in early trade on Monday after the US health regulator recommended a regulatory or an administrative action after the inspection of Roorkee manufacturing facility of the drug firm, according to a regulatory filing.

For more information on Indian Share Market Tips For Tomorrow

and quick free trial click here > 911 133 9000

Visit http://www.epicresearch.co

Connect with our social media sites
Next
« Prev Post
Previous
Next Post »